NYSE · CIK 0000064803 · RETAIL-DRUG STORES AND PROPRIETARY STORES
CVS HEALTH CORPORATION
CVS chart by TradingView
PRICE HISTORY
LIVE · NYSECVS chart by TradingView
- REVENUE FY2025 ENDED DEC 2025
- $402B
- EBITDA
- $9.3B
- FREE CASH FLOW
- $7.8B
- EPS
- $1.39
- GROSS MARGIN
- 44.99%
- ROIC
- —
Q2 FY26ENDED JUN 2026HOVERDRAG ACROSS ANY CHART TO SCRUB ALL 24 · 40 QUARTERS SHOWNVALUATIONGROWTHPROFITABILITY & RETURNSCASH & CAPITALBALANCE SHEET
VALUATION
what you pay for a unit of the business7 CHARTS⤢
P / E RATIO (TTM)
27.2x
+46%9.5x204.0x
⤢
P / SALES (TTM)
0.3x
-42%0.2x0.6x
⤢
P / BOOK
1.7x
-37%0.7x2.7x
⤢
EV / EBITDA (TTM)
—
-7%7.1x20.1x
⤢
EV / REVENUE (TTM)
—
-11%0.5x0.7x
⤢
FCF YIELD (TTM)
8.83%
-0.8pp2.13%19.87%
⤢
DIVIDEND YIELD (TTM)
2.57%
+0.7pp1.83%5.93%
GROWTH
is the business getting bigger5 CHARTS⤢
REVENUE
$106B
+138%⤢
EBITDA (DERIVED)
$5.8B
+70%⤢
NET INCOME
$3.0B
+93%⤢
EPS (DILUTED)
$2.31
+61%⤢
REVENUE GROWTH YOY
7.26%
-8.2pp2.60%36.47%
PROFITABILITY & RETURNS
what survives to the bottom, and what it earns on capital4 CHARTS⤢
FCF MARGIN
5.33%
-2.4pp-3.78%10.53%
⤢
RETURN ON CAPITAL
—
-2.4pp-0.47%10.80%
⤢
RETURN ON EQUITY (TTM)
6.14%
-8.1pp-1.02%17.57%
MARGIN FUNNEL
every line is a share of the same revenue, so they read on one scale — the gaps are what each layer takes out, and net rises above operating when income arrives from outside the businessGROSS MARGIN44.52%
OPERATING MARGIN4.43%
NET MARGIN2.81%
FCF MARGIN5.33%
CASH & CAPITAL
where the money actually goes5 CHARTS⤢
FREE CASH FLOW
$5.7B
+65%⤢
STOCK-BASED COMP
$0.2B
+198%⤢
CAPITAL EXPENDITURE
$0.7B
+37%⤢
SHARES OUTSTANDING
1.29B
+20%⤢
DIVIDEND / SHARE
$0.67
+56%BALANCE SHEET
how much cushion there is3 CHARTS⤢
CASH & EQUIVALENTS
$11.3B
+418%⤢
TOTAL DEBT
—
+179%⤢
DEBT / EBITDA (TTM)
—
+95%2.0x10.8x
OWNERSHIP
10 LARGEST HOLDERS · WHO OWNS THE FLOATINSTITUTIONS 89.75%INSIDERS 0.06%OTHER / RETAIL 10.19%2,577 INSTITUTIONAL FILERS
| HOLDER | % HELD | SHARES | VALUE | CHANGE |
|---|---|---|---|---|
| Blackrock Inc. | 9.85% | 125.9M | $12.05B | +4.1% |
| Vanguard Capital Management LLC | 6.46% | 82.7M | $7.91B | NEW |
| Capital World Investors | 6.04% | 77.2M | $7.39B | +14.2% |
| State Street Corporation | 4.64% | 59.3M | $5.68B | -1.4% |
| Dodge & Cox Inc. | 4.05% | 51.8M | $4.96B | -17.2% |
| FMR, LLC | 2.44% | 31.2M | $2.99B | -23.9% |
| JPMORGAN CHASE & CO | 2.31% | 29.5M | $2.83B | -5.4% |
| Geode Capital Management, LLC | 2.30% | 29.5M | $2.82B | +1.4% |
| Vanguard Portfolio Management LLC | 2.03% | 26.0M | $2.49B | NEW |
| Invesco Ltd. | 1.97% | 25.1M | $2.41B | +4.7% |
AS OF 2026-03-31 · MOST RECENT 13F FILINGS
SOURCE → 10-K · 10-Q · 8-K / GUIDANCE · ALL FILINGS
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.